Restarting Mounjaro After 2 Weeks Away From Treatment

The myth worth correcting first: a two-week break does not always mean going back to square one

The most common thing people assume when they've missed two injections is that they must return to the 2.5 mg starter pen. That belief is understandable (the titration schedule is built around tolerance) but it is not automatically correct. The Patient Information Leaflet for Mounjaro advises that if you have missed a dose by more than four days, you skip that injection and wait for your next scheduled one. A two-week gap is longer than that, which puts you in territory where clinical guidance, rather than a fixed rule, applies.

Your prescriber will weigh a few things: the dose you were on before the break, how settled your side effects were at that dose, and the reason for the gap. Someone who was stable and tolerating 10 mg with minimal nausea is in a different position from someone who had only just moved to 7.5 mg and was still adjusting. That context is exactly why this is a prescriber conversation, not a search-engine one.

The NHS tirzepatide guidance reinforces that any uncertainty about restarting after a missed dose should be resolved with your healthcare team. That advice holds especially when the gap runs to two weeks or more.

Why two weeks matters pharmacologically — and what it means for side effects

Tirzepatide has an elimination half-life of approximately five days. In practical terms, after two weeks without an injection, most of the medicine has left your system. That is not cause for alarm; it does explain why restarting at a higher dose carries a meaningful risk of gastric side effects returning (nausea, loose stools, that uncomfortable fullness after small meals) with a similar intensity to when you first started titrating up.

If your prescriber decides you should step back one dose level, it is not a sign that your treatment has failed. It is a sensible physiological decision. Pushing straight back to your previous dose because you want to avoid losing ground is a common temptation, and one worth resisting. The slower path almost always produces less disruption. Drinking plenty of water, keeping meals smaller and leaning on protein-rich foods during the readjustment window can all help with tolerability, practical habits backed by general dietary guidance from sources like NHS Live Well.

If your break extended beyond four weeks rather than two, the calculus shifts further, there is a separate discussion to be had about longer gaps, which our guide to restarting after a month covers in more detail.

What a prescriber actually looks at when you report a two-week gap

Feeling uncertain after missing treatment is completely understandable, especially if the break was unplanned, caused by supply issues or an illness that made injecting impractical. You are not the first patient to arrive at this question, and it is a legitimate clinical one.

When one of the prescribers at a regulated service like ours reviews a restart request, they are looking at the dose you were on, whether you had reached a stable maintenance phase or were mid-titration, any changes in your weight or health since the gap, and whether the original reason for treatment still applies. For a two-week break at a lower dose (2.5 or 5 mg), the answer is often to continue at the same level. At higher doses, stepping back one rung is common and protective.

The broader picture of how tirzepatide works as a dual GIP and GLP-1 receptor agonist (and what the clinical programme tells us about its effectiveness) is covered in our tirzepatide overview. For a full picture of Mounjaro specifically, including how it is supplied and what each pen contains, our Mounjaro page is the right starting point.

Practical steps before you inject again

Before restarting, check the pen you plan to use. If it has been stored outside the fridge for longer than the window specified in the Patient Information Leaflet, it should not be used. Storage requirements are precise and the leaflet is the authoritative source, do not estimate based on memory.

Make sure you have confirmed your restart plan with a prescriber. If you are with a service that offers clinical aftercare, a short message to your care team is all it takes. If you sourced treatment elsewhere and have no prescriber access, that is a gap worth closing, ongoing clinical oversight is not optional for a prescription medicine. Our frequently asked questions include guidance on what to expect from an ongoing treatment review.

If you are thinking about the financial side of treatment alongside the clinical one, our Mounjaro pricing page sets out what is included in a private prescription, which is a useful reference if you are weighing up your options. And if you are further along in your thinking and want a longer gap explained rather than a two-week one, our pages on restarting after three weeks and restarting after six weeks address those scenarios specifically.

If you would like a clinical review of your restart, our prescribers are available seven days a week. Check your eligibility and start a free consultation whenever you are ready.